Argus Research analyst John Eade initiates coverage on Oshkosh (NYSE:OSK) with a Hold rating.
‘White House transparency disputes imperil funds to buy Covid therapeutics’ -Stat News Report
https://www.statnews.com/2022/03/04/white-house-transparency-disputes-imperil-funds-to-buy-covid-therapeutics/